Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease
This study has been completed.
Study NCT00866359   Information provided by Celgene Corporation

First Received on March 18, 2009.   Last Updated on February 4, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Behcet Syndrome
More general conditions related to this trial
Cardiovascular Diseases
Eye Diseases
Mouth Diseases
Panuveitis
Skin Diseases
Skin Diseases, Vascular
Stomatognathic Diseases
Uveal Diseases
Uveitis
Uveitis, Anterior
Vascular Diseases
Vasculitis
Interventions listed in this trial
Apremilast (CC-10004)
Placebo
Sponsors listed in this trial
Celgene Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services